Help:Needs review/Missing review

From BugSigDB

This is a list of pages that have been marked as Complete but have not yet been reviewed.

Needs review
37978427/Experiment 2/Signature 2
A case report of malignant primary pericardial mesothelioma with atypical imaging appearance: multimodality imaging with histopathological correlation
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 1
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 1/Signature 1
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 1/Signature 2
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2/Signature 1
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2/Signature 2
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 3
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 3/Signature 1
A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 3/Signature 2
A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma/Experiment 1/Signature 1
A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma/Experiment 1/Signature 2
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents/Experiment 1
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents/Experiment 1/Signature 1
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents/Experiment 1/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 1/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 1/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 2/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 2/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 3
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 3/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 3/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 5
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 5/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 5/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 6
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 6/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 6/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 7
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 7/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 7/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 8
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 8/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 8/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 9
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 9/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 9/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 10
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 10/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 10/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 11
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 11/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 11/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 12
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 12/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 12/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 13
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 13/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 13/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 14
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 14/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 14/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15/Signature 2
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16/Signature 1
Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16/Signature 2
Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 1/Signature 1
Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 2/Signature 1
Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 2/Signature 2
Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 3
Almond Snacking for 8 wk Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen/Experiment 3/Signature 1
Alteration of the gut microbiota profile in children with autism spectrum disorder in China
Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1
Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1/Signature 1
Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1/Signature 2
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 1/Signature 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 1/Signature 2
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 4
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 4/Signature 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 4/Signature 2
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 6
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 6/Signature 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 6/Signature 2
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 7
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 7/Signature 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 7/Signature 2
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 8
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 8/Signature 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 8/Signature 2
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 11
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 11/Signature 1
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals/Experiment 11/Signature 2
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 2/Signature 1
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 2/Signature 2
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 4
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 4/Signature 1
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1/Signature 1
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1/Signature 2
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 2
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 2/Signature 1
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3/Signature 1
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3/Signature 2
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 1
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 2
Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet
Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 1
Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 1/Signature 1
Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 1/Signature 2
Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 2
Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 2/Signature 1
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1/Signature 1
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1/Signature 2
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 2
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 2/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 1/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 1/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 2/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 2/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 3
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 3/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 3/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 4
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 4/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 4/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 5
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 5/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 5/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 6
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 6/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 6/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 7
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 7/Signature 1
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 7/Signature 2
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 8
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 8/Signature 1
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 1
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 1/Signature 1
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 1/Signature 2
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 2
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 2/Signature 1
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway/Experiment 2/Signature 2
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2/Signature 1
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 2/Signature 2
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 1
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 1/Signature 1
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 2
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 2/Signature 1
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3/Signature 1
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3/Signature 2
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 4
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 4/Signature 1
Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 4/Signature 2
Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets
Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets/Experiment 1
Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets/Experiment 1/Signature 1
Analysis of strain, sex, and diet-dependent modulation of gut microbiota reveals candidate keystone organisms driving microbial diversity in response to American and ketogenic diets/Experiment 1/Signature 2
Analysis of the Conjunctival Microbiome in Patients with Atopic Keratoconjunctivitis and Healthy Individuals/Experiment 1/Signature 3
APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease/Experiment 1
APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease/Experiment 1/Signature 1
APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease/Experiment 1/Signature 2
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 1
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 1/Signature 1
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 1/Signature 2
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 2
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 2/Signature 1
Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 2/Signature 2
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 1
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 1/Signature 1
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 1/Signature 2
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 2
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 2/Signature 1
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 2/Signature 2
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 3
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 3/Signature 1
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly/Experiment 3/Signature 2
Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults
Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 1
Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 1/Signature 1
Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 1/Signature 2
Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 2
Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 2/Signature 1
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 1
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 1/Signature 1
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 1/Signature 2
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 2
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 2/Signature 1
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 2/Signature 2
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 3
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 3/Signature 1
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 3/Signature 2
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 4
Associations between bacterial and fungal communities in the human gut microbiota and their implications for nutritional status and body weight/Experiment 4/Signature 1
Bifidobacteria support optimal infant vaccine responses/Experiment 1/Signature 1
Bifidobacteria support optimal infant vaccine responses/Experiment 1/Signature 2
Bifidobacteria support optimal infant vaccine responses/Experiment 1/Signature 3
Bifidobacteria support optimal infant vaccine responses/Experiment 2
Bifidobacteria support optimal infant vaccine responses/Experiment 2/Signature 1
Bifidobacteria support optimal infant vaccine responses/Experiment 2/Signature 2
Bifidobacteria support optimal infant vaccine responses/Experiment 3
Bifidobacteria support optimal infant vaccine responses/Experiment 3/Signature 1
Blue poo: impact of gut transit time on the gut microbiome using a novel marker/Experiment 2/Signature 1
Body site-typical microbiome signatures for children/Experiment 2
Body site-typical microbiome signatures for children/Experiment 2/Signature 1
Body site-typical microbiome signatures for children/Experiment 2/Signature 2
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria/Experiment 2
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria/Experiment 2/Signature 1
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria/Experiment 2/Signature 2
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice/Experiment 1
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice/Experiment 1/Signature 1
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice/Experiment 2
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice/Experiment 2/Signature 1
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice/Experiment 3
Cannabis sativa L. alleviates loperamide-induced constipation by modulating the composition of gut microbiota in mice/Experiment 3/Signature 1
Captive environments reshape the compositions of carbohydrate active enzymes and virulence factors in wolf gut microbiome
Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 1
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 1/Signature 1
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 1/Signature 2
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 2
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 2/Signature 1
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 2/Signature 2
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 3
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 3/Signature 1
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women/Experiment 3/Signature 2
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 1
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 1/Signature 1
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 1/Signature 2
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 2
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 2/Signature 1
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 2/Signature 2
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 3
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 3/Signature 1
Changes in the gut microbiome associated with infliximab in patients with bipolar disorder
Changes in the gut microbiome associated with infliximab in patients with bipolar disorder/Experiment 1
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 1
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 1/Signature 1
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 1/Signature 2
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 2
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 1/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 2
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 2/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 2/Signature 2
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 3
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 3/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 4
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 4/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 5
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 5/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 6
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 6/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 7
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 7/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 8
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 8/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 9
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 9/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 10
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 10/Signature 1
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 11
Changes in the vaginal microbiome during pregnancy and the postpartum period in South African women: a longitudinal study/Experiment 11/Signature 1
Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients
Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients/Experiment 1
Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients/Experiment 1/Signature 1
Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients/Experiment 1/Signature 2
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome/Experiment 1
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome/Experiment 1/Signature 1
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome/Experiment 1/Signature 2
Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples
Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples/Experiment 1
Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples/Experiment 1/Signature 1
Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples/Experiment 1/Signature 2
Classifying dementia progression using microbial profiling of saliva
Classifying dementia progression using microbial profiling of saliva/Experiment 1
Classifying dementia progression using microbial profiling of saliva/Experiment 1/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 1/Signature 2
Classifying dementia progression using microbial profiling of saliva/Experiment 2
Classifying dementia progression using microbial profiling of saliva/Experiment 2/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 2/Signature 2
Classifying dementia progression using microbial profiling of saliva/Experiment 3
Classifying dementia progression using microbial profiling of saliva/Experiment 3/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 4
Classifying dementia progression using microbial profiling of saliva/Experiment 4/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 5
Classifying dementia progression using microbial profiling of saliva/Experiment 5/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 5/Signature 2
Classifying dementia progression using microbial profiling of saliva/Experiment 6
Classifying dementia progression using microbial profiling of saliva/Experiment 6/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 6/Signature 2
Classifying dementia progression using microbial profiling of saliva/Experiment 7
Classifying dementia progression using microbial profiling of saliva/Experiment 7/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 7/Signature 2
Classifying dementia progression using microbial profiling of saliva/Experiment 8
Classifying dementia progression using microbial profiling of saliva/Experiment 8/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 8/Signature 2
Classifying dementia progression using microbial profiling of saliva/Experiment 9
Classifying dementia progression using microbial profiling of saliva/Experiment 9/Signature 1
Classifying dementia progression using microbial profiling of saliva/Experiment 9/Signature 2
Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study
Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study/Experiment 1
Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study/Experiment 1/Signature 1
Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study/Experiment 1/Signature 2
Comparison of Small Gut and Whole Gut Microbiota of First-Degree Relatives With Adult Celiac Disease Patients and Controls/Experiment 1/Signature 2
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 2
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 2/Signature 1
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 2/Signature 2
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3/Signature 1
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3/Signature 2
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 4
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 4/Signature 1
Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 4/Signature 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 1
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 1/Signature 1
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 1/Signature 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 2/Signature 1
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 2/Signature 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 3
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 3/Signature 1
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 3/Signature 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 4
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 4/Signature 1
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 4/Signature 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 5
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 5/Signature 1
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 5/Signature 2
Correlation between slow transit constipation and spleen deficiency, and gut microbiota: a pilot study/Experiment 6
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 1/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 2/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 3
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 3/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 4
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 4/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 4/Signature 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 5
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 5/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 5/Signature 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 6
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 6/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 6/Signature 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 7
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 7/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 7/Signature 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 8
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 8/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 8/Signature 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 9
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 9/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 9/Signature 2
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 10
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 10/Signature 1
Correlations Between Amelioration of Rotenone-Induced Parkinson's Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice/Experiment 10/Signature 2
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease/Experiment 3/Signature 2
Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma/Experiment 1
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns/Experiment 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 1/Signature 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 1/Signature 2
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 2
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 2/Signature 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 2/Signature 2
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 3
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 3/Signature 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 3/Signature 2
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 4
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 4/Signature 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 4/Signature 2
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 5
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 5/Signature 1
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice/Experiment 5/Signature 2
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 1
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 1/Signature 1
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 1/Signature 2
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 2
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 2/Signature 1
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 2/Signature 2
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 3
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 3/Signature 1
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 3/Signature 2
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 4
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 4/Signature 1
Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 4/Signature 2
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 1
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 1/Signature 1
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 2
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 2/Signature 1
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 3
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 3/Signature 1
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 4
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 4/Signature 1
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 5
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 5/Signature 1
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 6
Dietary Supplementation With Leucine or in Combination With Arginine Decreases Body Fat Weight and Alters Gut Microbiota Composition in Finishing Pigs/Experiment 6/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 1/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 1/Signature 2
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 2
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 2/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 2/Signature 2
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 3
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 3/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 3/Signature 2
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 4
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 4/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 4/Signature 2
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 5
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 5/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 5/Signature 2
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 6
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 6/Signature 1
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 6/Signature 2
Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 4/Signature 2
Different Efficacy of Five Soluble Dietary Fibers on Alleviating Loperamide-Induced Constipation in Mice: Influences of Different Structural Features/Experiment 9/Signature 1
Different Efficacy of Five Soluble Dietary Fibers on Alleviating Loperamide-Induced Constipation in Mice: Influences of Different Structural Features/Experiment 14/Signature 1
Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients/Experiment 6/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 4
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 4/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 4/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 7
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 7/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 7/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 8
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 8/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 8/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 9
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 9/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 9/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 10
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 10/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 10/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 11
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 11/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 12
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 12/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 13
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 13/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 15
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 15/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 15/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 16
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 16/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 16/Signature 2
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17/Signature 1
Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17/Signature 2
Distinct Genetic and Functional Traits of Human Intestinal Prevotella copri Strains Are Associated with Different Habitual Diets
Distinct Genetic and Functional Traits of Human Intestinal Prevotella copri Strains Are Associated with Different Habitual Diets/Experiment 1
Distinct Genetic and Functional Traits of Human Intestinal Prevotella copri Strains Are Associated with Different Habitual Diets/Experiment 1/Signature 1
Distinct Genetic and Functional Traits of Human Intestinal Prevotella copri Strains Are Associated with Different Habitual Diets/Experiment 1/Signature 2
Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial
Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway
Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs
Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs/Experiment 1
Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs/Experiment 1/Signature 1
Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs/Experiment 1/Signature 2
Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs/Experiment 2
Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs/Experiment 2/Signature 1
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice/Experiment 1
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice/Experiment 1/Signature 1
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice/Experiment 1/Signature 2
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice/Experiment 2
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice/Experiment 2/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 1/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 1/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 2/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 2/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 3
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 3/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 4
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 4/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 4/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 5
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 5/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 5/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 6
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 6/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 6/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 7
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 7/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 7/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 8
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 8/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 8/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 9
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 9/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 9/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 10
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 10/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 10/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 11
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 11/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 11/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 12
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 12/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 12/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 13
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 13/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 14
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 14/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 15
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 15/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 15/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 16
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 16/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 16/Signature 2
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 17/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 18
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 18/Signature 1
Effects of Vegetable and Fruit Juicing on Gut and Oral Microbiome Composition/Experiment 18/Signature 2
Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome
Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1
Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1/Signature 1
Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1/Signature 2
Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 2/Signature 1
Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 4
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 1
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 1/Signature 1
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 1/Signature 2
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 2
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 2/Signature 1
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 2/Signature 2
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 3
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 3/Signature 1
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 3/Signature 2
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4/Signature 1
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4/Signature 2
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 5
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 5/Signature 1
Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 5/Signature 2
Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway/Experiment 1/Signature 2
Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn's disease/Experiment 18/Signature 2
Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans/Experiment 2/Signature 2
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1/Signature 2
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 2
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 2/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 3
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 3/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 4
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 5
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 5/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 6
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 6/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 7
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 7/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 8
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 9
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 9/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 10
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 11
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 12
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 12/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 13
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 13/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 14
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 14/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 15
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 16
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 16/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 17
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 17/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 18
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 18/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 19
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 19/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 20
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 21
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 21/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 22
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 22/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 23
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 23/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 24
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 24/Signature 1
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 25
Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 25/Signature 1
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 2
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 2/Signature 1
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 2/Signature 2
Fecal microbiota transplantation restores normal fecal composition and delays malignant development of mild chronic kidney disease in rats
Fecal microbiota transplantation restores normal fecal composition and delays malignant development of mild chronic kidney disease in rats/Experiment 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 1/Signature 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 1/Signature 2
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 2
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 2/Signature 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 2/Signature 2
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 3
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 3/Signature 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 4
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 4/Signature 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 4/Signature 2
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 5
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 5/Signature 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 6
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 6/Signature 1
Fermented foods affect the seasonal stability of gut bacteria in an Indian rural population/Experiment 6/Signature 2
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 1/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 1/Signature 2
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 2
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 2/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 2/Signature 2
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 3
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 3/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 3/Signature 2
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 4
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 4/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 5
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 5/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 6
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 6/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 7
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 7/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 7/Signature 2
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 8
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 8/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 9
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 9/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 10
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 10/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 11
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 11/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 12
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 12/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 13
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 13/Signature 1
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 14
Formulation of traditional Chinese medicine and its application on intestinal flora of constipated rats/Experiment 14/Signature 1
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 1
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 1/Signature 1
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 1/Signature 2
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 2
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 2/Signature 1
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 2/Signature 2
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 3
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 3/Signature 1
Genomic and functional co-diversification imprint African Hominidae microbiomes to signal dietary and lifestyle adaptations/Experiment 3/Signature 2
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 1/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 1/Signature 2
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 2
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 2/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 2/Signature 2
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 3
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 3/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 3/Signature 2
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 5
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 5/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 6
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 6/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 7
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 7/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 7/Signature 2
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 8
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 8/Signature 1
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets/Experiment 8/Signature 2
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 1
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 1/Signature 1
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 1/Signature 2
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 2
Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders/Experiment 2/Signature 1
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation/Experiment 7/Signature 2
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 1/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 2
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 2/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3/Signature 2
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4/Signature 2
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5/Signature 2
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 6
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 6/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 7
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 7/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 8
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 8/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 9
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 9/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 10
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 10/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 11
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 11/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 12
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 12/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 13
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 13/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 14
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 14/Signature 1
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 15
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 15/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 1/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 1/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 2/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 2/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 3
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 3/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 3/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 4
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 4/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 4/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 5
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 5/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 5/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 6
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 6/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 6/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 7
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 7/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 7/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 8
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 8/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 8/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 9
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 9/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 9/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 10
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 10/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 10/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 11
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 11/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 11/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 12
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 12/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 13
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 13/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 13/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 14
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 14/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 15
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 15/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 16
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 16/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 16/Signature 2
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 17
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 17/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 18
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 18/Signature 1
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 19
Gut microbiome alterations precede graft rejection in kidney transplantation patients/Experiment 19/Signature 1
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis/Experiment 1
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis/Experiment 1/Signature 1
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis/Experiment 2
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis/Experiment 2/Signature 1
Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis/Experiment 2/Signature 2
Gut microbiome composition in the Hispanic Community Health Study/Study of Latinos is shaped by geographic relocation, environmental factors, and obesity/Experiment 5
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 1
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 1/Signature 1
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 1/Signature 2
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 2
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 2/Signature 1
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 2/Signature 2
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 3
Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment/Experiment 3/Signature 1
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 1
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 1/Signature 1
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 2
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 2/Signature 1
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 3
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 3/Signature 1
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 3
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 4
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 5
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 6
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 1
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 1/Signature 1
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 1/Signature 2
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 2
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 2/Signature 1
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 2/Signature 2
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 3
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 3/Signature 1
Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals/Experiment 3/Signature 2
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 1
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 1/Signature 1
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 1/Signature 2
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 2
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 2/Signature 1
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 2/Signature 2
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 3
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 3/Signature 1
Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 3/Signature 2
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 1
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 1/Signature 1
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 1/Signature 2
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 2
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 2/Signature 1
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 2/Signature 2
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 3
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 3/Signature 1
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 4
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 4/Signature 1
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 4/Signature 2
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 5
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 5/Signature 1
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 6
Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients/Experiment 6/Signature 1
Gut Microbiota Are Associated With Psychological Stress-Induced Defections in Intestinal and Blood-Brain Barriers
Gut Microbiota Are Associated With Psychological Stress-Induced Defections in Intestinal and Blood-Brain Barriers/Experiment 1
Gut Microbiota Are Associated With Psychological Stress-Induced Defections in Intestinal and Blood-Brain Barriers/Experiment 1/Signature 1
Gut Microbiota Are Associated With Psychological Stress-Induced Defections in Intestinal and Blood-Brain Barriers/Experiment 1/Signature 2
Gut microbiota changes in patients with autism spectrum disorders
Gut microbiota changes in patients with autism spectrum disorders/Experiment 1
Gut microbiota changes in patients with autism spectrum disorders/Experiment 1/Signature 1
Gut microbiota changes in patients with autism spectrum disorders/Experiment 1/Signature 2
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 1/Signature 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 2
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 2/Signature 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 3
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 3/Signature 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 4
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 4/Signature 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 5
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 5/Signature 2
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 6
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 6/Signature 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 6/Signature 2
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 7
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 7/Signature 1
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 7/Signature 2
Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 8
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 1
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 1/Signature 1
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 1/Signature 2
Gut Microbiota Features in Young Children With Autism Spectrum Disorders
Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 1
Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 1/Signature 1
Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 1/Signature 2
Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 2
Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 2/Signature 1
Gut Microbiota Features in Young Children With Autism Spectrum Disorders/Experiment 2/Signature 2
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 1
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 1/Signature 1
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 1/Signature 2
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 2
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 2/Signature 1
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 2/Signature 2
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 3
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 3/Signature 1
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 3/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 1/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 1/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 2/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 2/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 3
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 3/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 3/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 4
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 4/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 4/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 5
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 5/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 5/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 6
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 6/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 6/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 7
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 7/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 7/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 8
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 8/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 8/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 9
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 9/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 9/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 10
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 10/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 11
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 11/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 11/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 12
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 12/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 12/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 13
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 13/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 13/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 14
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 14/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 14/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 15
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 15/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 15/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 16
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 16/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 16/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 16/Signature 3
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 17
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 17/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 17/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 18
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 18/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 19
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 19/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 19/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 20
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 20/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 20/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 21
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 21/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22/Signature 3
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22/Signature 4
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 23
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 23/Signature 1
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 23/Signature 2
Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 24
Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors/Experiment 3/Signature 1
Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors/Experiment 3/Signature 2
Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors/Experiment 4/Signature 1
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 1
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 1/Signature 1
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 1/Signature 2
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 2
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 2/Signature 1
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 2/Signature 2
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 3
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 3/Signature 1
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 4
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 4/Signature 1
Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia/Experiment 4/Signature 2
Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time
Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1
Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1/Signature 1
Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1/Signature 2
Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1/Signature 3
Gut microbiota: impacts on gastrointestinal cancer immunotherapy/Experiment 1/Signature 2
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome/Experiment 1
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome/Experiment 1/Signature 2
Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet
Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 1
Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 1/Signature 1
Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 4
Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet/Experiment 4/Signature 1
Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 12
Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 12/Signature 1
[2/Signature 1|Https://doi.org]
[1/Signature 1|Https://doi.org]
[[1]]
[[2]]
[[3]]
[1|Https:/Experiment 1]
[2|Https:/Experiment 2]
[3|Https:/Experiment 3]
Human gut microbiota adaptation to high-altitude exposure: longitudinal analysis over acute and prolonged periods/Experiment 1
Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 2
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 1
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 1/Signature 1
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 1/Signature 2
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 2
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 2/Signature 1
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders/Experiment 2/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 1/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 1/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 2/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 2/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 3
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 3/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 3/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 4
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 4/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 4/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 5
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 5/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 5/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 6
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 6/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 6/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 7
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 7/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 7/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 8
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 8/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 8/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 9
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 9/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 9/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 10
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 10/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 10/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 11
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 11/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 11/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 12
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 12/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 12/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 13
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 13/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 13/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 14
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 14/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 14/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 15
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 15/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 15/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 16
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 16/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 16/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 17
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 17/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 17/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 18
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 18/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 18/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 19
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 19/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 19/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 20
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 20/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 20/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 21
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 21/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 21/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 22
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 23
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 24
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 25
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 25/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 25/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 26
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 26/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 26/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 27
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 27/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 27/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 28
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 28/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 28/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 29
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 29/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 29/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 30
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 30/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 30/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 31
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 31/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 31/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 32
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 32/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 32/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 33
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 33/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 33/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 34
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 34/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 34/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 35
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 35/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 35/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 36
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 36/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 36/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 37
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 37/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 37/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 38
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 38/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 38/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 39
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 39/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 39/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 40
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 40/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 40/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 41
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 41/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 41/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 42
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 42/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 42/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 43
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 43/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 43/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 44
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 44/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 44/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 45
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 45/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 45/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 46
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 47
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 48
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 49
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 49/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 49/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 50
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 50/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 50/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 51
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 51/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 51/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 52
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 52/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 52/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 53
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 53/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 53/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 54
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 54/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 54/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 55
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 55/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 55/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 56
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 56/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 56/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 57
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 57/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 57/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 58
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 58/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 58/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 59
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 59/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 59/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 60
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 60/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 60/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 61
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 61/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 61/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 62
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 62/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 62/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 63
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 63/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 63/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 64
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 64/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 64/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 65
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 65/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 65/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 66
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 66/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 66/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 67
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 67/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 67/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 68
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 68/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 68/Signature 2
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 69
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 69/Signature 1
Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 69/Signature 2
Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome/Experiment 1
Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis/Experiment 1
Influence of cigarette smoking on the human duodenal mucosa-associated microbiota
Influence of cigarette smoking on the human duodenal mucosa-associated microbiota/Experiment 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 1/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 1/Signature 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 2/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 2/Signature 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 3
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 3/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 3/Signature 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 4
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 4/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 4/Signature 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 5
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 5/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 5/Signature 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 6
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 6/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 6/Signature 2
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 7
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 7/Signature 1
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 8
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model/Experiment 8/Signature 1
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet/Experiment 1
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet/Experiment 1/Signature 1
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet/Experiment 1/Signature 2
Integrating respiratory microbiome and host immune response through machine learning for respiratory tract infection diagnosis
Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 1
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 1/Signature 1
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 1/Signature 2
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 2
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 2/Signature 1
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 2/Signature 2
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 3
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 3/Signature 1
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 3/Signature 2
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 4
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 4/Signature 1
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 4/Signature 2
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 5
Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19/Experiment 5/Signature 1
Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial
Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 1
Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 1/Signature 1
Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 2
Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 2/Signature 1
Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients/Experiment 1
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 3
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 3/Signature 2
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 1
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 1/Signature 1
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 1/Signature 2
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2/Signature 1
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 2/Signature 2
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 3
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 3/Signature 1
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 4
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 4/Signature 1
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 5
Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy/Experiment 5/Signature 1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 1/Signature 1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 1/Signature 2
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 2
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3/Signature 1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3/Signature 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 1/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 1/Signature 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 2/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 2/Signature 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 3
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 3/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 3/Signature 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 4
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 4/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 4/Signature 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 5
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 5/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 5/Signature 2
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 6
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 6/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 7
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 7/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 8
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 8/Signature 1
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 9
Ketogenic Diets Alter the Gut Microbiome, Resulting in Decreased Susceptibility to and Cognitive Impairment in Rats with Pilocarpine-Induced Status Epilepticus/Experiment 9/Signature 1
Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life
Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life/Experiment 1
Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life/Experiment 1/Signature 1
Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life/Experiment 1/Signature 2
Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study
Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis
Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis/Experiment 1
Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis/Experiment 1/Signature 1
Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis/Experiment 1/Signature 2
Linking long-term dietary patterns with gut microbial enterotypes
Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1
Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1/Signature 1
Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1/Signature 2
Linking long-term dietary patterns with gut microbial enterotypes/Experiment 2
Linking long-term dietary patterns with gut microbial enterotypes/Experiment 2/Signature 1
Linking long-term dietary patterns with gut microbial enterotypes/Experiment 2/Signature 2
Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects
Longitudinal and Comparative Analysis of Gut Microbiota of Tunisian Newborns According to Delivery Mode/Experiment 6/Signature 1
Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1
Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1/Signature 1
Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1/Signature 2
Lower respiratory tract microbiome composition and community interactions in smokers/Experiment 6
Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study
Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 1
Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 1/Signature 1
Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 2
Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 2/Signature 1
Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study/Experiment 2/Signature 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 1/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 1/Signature 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 2/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 2/Signature 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 3
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 3/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 4
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 4/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 4/Signature 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 5
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 5/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 5/Signature 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 6
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 6/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 6/Signature 2
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 7
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 7/Signature 1
Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 7/Signature 2
Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery/Experiment 2/Signature 1
Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations/Experiment 3/Signature 2
Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations/Experiment 3/Signature 3
Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations/Experiment 3/Signature 4
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1/Signature 1
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1/Signature 2
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer/Experiment 1/Signature 3
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation/Experiment 1
Metagenomic gut microbiome analysis of Japanese patients with multiple chemical sensitivity/idiopathic environmental intolerance/Experiment 1/Signature 1
Metagenomic gut microbiome analysis of Japanese patients with multiple chemical sensitivity/idiopathic environmental intolerance/Experiment 1/Signature 2
Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese
Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese
Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese/Experiment 1
Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese/Experiment 1/Signature 1
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 1/Signature 1
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 1/Signature 2
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 3/Signature 1
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes/Experiment 3/Signature 2
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease/Experiment 1
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease/Experiment 1/Signature 1
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease/Experiment 1/Signature 2
Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance
Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance/Experiment 1
Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance/Experiment 1/Signature 1
Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance/Experiment 1/Signature 2
Microbial communities associated with honey bees in Brazil and in the United States
Microbial communities associated with honey bees in Brazil and in the United States/Experiment 1
Microbial communities associated with honey bees in Brazil and in the United States/Experiment 1/Signature 1
Microbial communities associated with honey bees in Brazil and in the United States/Experiment 1/Signature 2
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 1
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 1/Signature 3
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 2
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 2/Signature 1
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 2/Signature 2
Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1
Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1/Signature 1
Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1/Signature 2
Microbiota changes in a pediatric acute lymphocytic leukemia mouse model/Experiment 2
Microbiota changes in a pediatric acute lymphocytic leukemia mouse model/Experiment 2/Signature 1
Microbiota changes in a pediatric acute lymphocytic leukemia mouse model/Experiment 2/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 1/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 1/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 2/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 2/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 3
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 3/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 3/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 4
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 4/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 4/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 5
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 5/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 5/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 6
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 6/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 6/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 7
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 7/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 7/Signature 2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 8
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 8/Signature 1
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota/Experiment 8/Signature 2
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition/Experiment 4
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis/Experiment 13/Signature 2
Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients
Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients/Experiment 1
Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients/Experiment 1/Signature 1
Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients/Experiment 1/Signature 2
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 1
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 1/Signature 1
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 2
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 3
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 1
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 1/Signature 1
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 1/Signature 2
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 2
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 2/Signature 1
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 2/Signature 2
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 3
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 3/Signature 1
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 3/Signature 2
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 4
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 4/Signature 1
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety/Experiment 4/Signature 2
Multi-omics analysis reveals gut microbiota-ovary axis contributed to the follicular development difference between Meishan and Landrace × Yorkshire sows
Multi-omics analysis reveals gut microbiota-ovary axis contributed to the follicular development difference between Meishan and Landrace × Yorkshire sows/Experiment 1
Multi-omics analysis reveals gut microbiota-ovary axis contributed to the follicular development difference between Meishan and Landrace × Yorkshire sows/Experiment 1/Signature 1
Multi-omics analysis reveals gut microbiota-ovary axis contributed to the follicular development difference between Meishan and Landrace × Yorkshire sows/Experiment 1/Signature 2
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 1
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 1/Signature 1
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 1/Signature 2
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 3
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 3/Signature 1
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 3/Signature 2
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 4
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 4/Signature 1
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 5
Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 5/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 1/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 1/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 2/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 2/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 3
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 3/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 3/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 4
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 4/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 4/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 5
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 5/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 5/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 6
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 6/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 6/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 7
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 7/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 7/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 8
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 8/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 8/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 9
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 9/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 10
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 10/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 11
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 11/Signature 1
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 11/Signature 2
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 12
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study/Experiment 12/Signature 1
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients/Experiment 1
Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats via Targeting Gut Microbiota
Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats via Targeting Gut Microbiota/Experiment 1
Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats via Targeting Gut Microbiota/Experiment 1/Signature 1
Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats via Targeting Gut Microbiota/Experiment 1/Signature 2
Ocular surface microbiota in patients with varying degrees of dry eye severity
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 1
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 1/Signature 1
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 1/Signature 2
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 2
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 2/Signature 1
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 2/Signature 2
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 3
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 3/Signature 1
Ocular surface microbiota in patients with varying degrees of dry eye severity/Experiment 3/Signature 2
Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 2
Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 2/Signature 1
Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients/Experiment 2/Signature 2
Oral microbiome and obesity in a large study of low-income and African-American populations
Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 1
Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 1/Signature 1
Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2
Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2/Signature 1
Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2/Signature 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 1/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 1/Signature 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 2/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 2/Signature 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 3
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 3/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 3/Signature 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 4
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 4/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 4/Signature 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 5
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 5/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 6
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 6/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 6/Signature 2
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 7
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 7/Signature 1
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer/Experiment 7/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 1/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 1/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 2/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 3
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 3/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 3/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 4
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 4/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 4/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 5
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 5/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 5/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 6
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 6/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 6/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 7
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 7/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 8
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 8/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 8/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 9
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 9/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 9/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 10
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 10/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 10/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 11
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 11/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 11/Signature 2
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 12
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 12/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 13
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 13/Signature 1
Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 13/Signature 2
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 1
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 1/Signature 1
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 1/Signature 2
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 2
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 2/Signature 1
Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease/Experiment 2/Signature 2
Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children
Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1
Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1/Signature 1
Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1/Signature 2
Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 7/Signature 2
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 1
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 1/Signature 1
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 2
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 2/Signature 1
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 3
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 3/Signature 1
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4/Signature 1
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4/Signature 2
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5/Signature 1
Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5/Signature 2
Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota
Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota/Experiment 1
Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota/Experiment 1/Signature 1
Overweight and Obesity in Children Are Associated with an Abundance of Firmicutes and Reduction of Bifidobacterium in Their Gastrointestinal Microbiota/Experiment 1/Signature 2
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 6/Signature 1
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 8/Signature 1
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 16/Signature 1
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 17/Signature 1
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 17/Signature 2
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 19/Signature 1
Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet/Experiment 20/Signature 1
Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana
Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana/Experiment 1
Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana/Experiment 1/Signature 1
Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana/Experiment 1/Signature 2
Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder
Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder/Experiment 1
Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder/Experiment 1/Signature 1
Potential role of fecal microbiota in patients with constipation
Potential role of fecal microbiota in patients with constipation/Experiment 1
Potential role of fecal microbiota in patients with constipation/Experiment 1/Signature 1
Potential role of fecal microbiota in patients with constipation/Experiment 2
Potential role of fecal microbiota in patients with constipation/Experiment 2/Signature 1
Potential role of fecal microbiota in patients with constipation/Experiment 3
Potential role of fecal microbiota in patients with constipation/Experiment 3/Signature 1
Potential role of fecal microbiota in patients with constipation/Experiment 4
Potential role of fecal microbiota in patients with constipation/Experiment 4/Signature 1
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 1
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 1/Signature 1
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 1/Signature 2
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 2
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 2/Signature 1
Pre-obese children's dysbiotic gut microbiome and unhealthy diets may predict the development of obesity/Experiment 2/Signature 2
Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort
Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 1
Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 1/Signature 1
Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 2
Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort/Experiment 2/Signature 1
Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome
Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome/Experiment 1
Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome/Experiment 1/Signature 1
Prenatal and Peripartum Exposure to Antibiotics and Cesarean Section Delivery Are Associated with Differences in Diversity and Composition of the Infant Meconium Microbiome/Experiment 1/Signature 2
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 1
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 1/Signature 1
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 1/Signature 2
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 2
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 2/Signature 1
Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units/Experiment 2/Signature 2
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1/Signature 1
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1/Signature 2
Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01
Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01/Experiment 1
Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01/Experiment 1/Signature 1
Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01/Experiment 1/Signature 2
Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01/Experiment 3
Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by Ligilactobacillus salivarius Li01/Experiment 3/Signature 1
Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure
Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1
Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1/Signature 1
Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 1/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 1/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 2/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 2/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 3
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 3/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 3/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 4
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 4/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 4/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 5
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 5/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 5/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 6
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 6/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 7
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 7/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 7/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 8
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 8/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 8/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 9
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 9/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 9/Signature 2
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 10
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 10/Signature 1
Profiling the oral microbiomes in patients with Alzheimer's disease/Experiment 10/Signature 2
Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage
Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1
Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1/Signature 1
Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1/Signature 2
Protection of the Human Gut Microbiome From Antibiotics
Protection of the Human Gut Microbiome From Antibiotics/Experiment 1/Signature 1
Protection of the Human Gut Microbiome From Antibiotics/Experiment 1/Signature 2
Protection of the Human Gut Microbiome From Antibiotics/Experiment 2
Protection of the Human Gut Microbiome From Antibiotics/Experiment 2/Signature 1
Protection of the Human Gut Microbiome From Antibiotics/Experiment 2/Signature 2
Protection of the Human Gut Microbiome From Antibiotics/Experiment 3
Protection of the Human Gut Microbiome From Antibiotics/Experiment 3/Signature 1
Protection of the Human Gut Microbiome From Antibiotics/Experiment 3/Signature 2
Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic
Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 1
Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 1/Signature 1
Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 1/Signature 2
Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls
Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls/Experiment 1
Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls/Experiment 1/Signature 1
Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls/Experiment 1/Signature 2
Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children
Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children/Experiment 1
Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children/Experiment 1/Signature 1
Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry/Experiment 1
Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry/Experiment 1/Signature 1
Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry/Experiment 1/Signature 2
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1/Signature 1
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1/Signature 2
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 2
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 2/Signature 1
Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 2/Signature 2
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 1
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 1/Signature 1
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 1/Signature 2
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 2
Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis/Experiment 2/Signature 1
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease/Experiment 1/Signature 2
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1/Signature 1
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1/Signature 2
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2/Signature 1
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2/Signature 2
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 3
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 3/Signature 1
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 3/Signature 2
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 4
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 4/Signature 1
Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation
Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1
Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1/Signature 1
Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1/Signature 2
Reduced microbiome alpha diversity in young patients with ADHD
Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1
Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1/Signature 1
Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1/Signature 2
Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study
Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1
Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1/Signature 1
Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1/Signature 2
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 1
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 1/Signature 1
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 1/Signature 2
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 2
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 2/Signature 1
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 2/Signature 2
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 3
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 3/Signature 1
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 3/Signature 2
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 4
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 4/Signature 1
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 5
Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer/Experiment 5/Signature 1
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease/Experiment 1
Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1/Signature 2
Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 2
Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 2/Signature 1
Resilience of the respiratory microbiome in controlled adult RSV challenge study
Resilience of the respiratory microbiome in controlled adult RSV challenge study/Experiment 1
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 1
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 1/Signature 1
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 1/Signature 2
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2/Signature 1
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2/Signature 2
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3/Signature 1
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 1/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 1/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 2/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 2/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 3
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 3/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 3/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 4
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 4/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 4/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 5
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 5/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 5/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 6
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 6/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 6/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 7
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 7/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 7/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 8
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 8/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 8/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 9
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 9/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 9/Signature 2
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 11
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 11/Signature 1
Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 11/Signature 2
SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition
SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition/Experiment 1
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans/Experiment 1
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans/Experiment 1/Signature 1
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans/Experiment 1/Signature 2
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans/Experiment 2
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans/Experiment 2/Signature 1
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans/Experiment 2/Signature 2
Shift in skin microbiota of Western European women across aging
Shift in skin microbiota of Western European women across aging/Experiment 1
Shift in skin microbiota of Western European women across aging/Experiment 1/Signature 1
Shift in skin microbiota of Western European women across aging/Experiment 1/Signature 2
Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1
Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1/Signature 1
Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1/Signature 2
Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial
Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial/Experiment 1
Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial/Experiment 1/Signature 1
Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial/Experiment 1/Signature 2
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome/Experiment 1
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome/Experiment 1/Signature 1
37179374/Experiment 1/Signature 2
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome/Experiment 2
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome/Experiment 2/Signature 1
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome/Experiment 3
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome/Experiment 3/Signature 1
Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study
Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study/Experiment 1
Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study/Experiment 1/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 1/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 1/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 2/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 2/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 3
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 3/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 3/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 4
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 4/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 4/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 5
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 5/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 5/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 6
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 6/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 6/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 7
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 7/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 7/Signature 2
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 8
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 8/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 9
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 9/Signature 1
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 10
Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 10/Signature 1
Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood
Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood/Experiment 1
Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood/Experiment 1/Signature 1
Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood/Experiment 1/Signature 2
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1/Signature 1
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1/Signature 2
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 2
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 2/Signature 1
Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year
Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year/Experiment 1
Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year/Experiment 1/Signature 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 1/Signature 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 1/Signature 2
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 2
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 2/Signature 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 2/Signature 2
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 3
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 3/Signature 2
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 4
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 4/Signature 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 4/Signature 2
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 5
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 5/Signature 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 5/Signature 2
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 6
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 6/Signature 1
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 6/Signature 2
Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study
Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study/Experiment 1
Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study/Experiment 1/Signature 1
Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study/Experiment 1/Signature 2
Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study/Experiment 4
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 1
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 1/Signature 1
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 1/Signature 2
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 2
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 2/Signature 1
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 2/Signature 2
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 3
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 3/Signature 1
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 3/Signature 2
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 4
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 4/Signature 1
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 4/Signature 2
Study 11
Study 11/Experiment 1
Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1
Study 39
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 1
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 2
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2/Signature 1
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3
Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3/Signature 1
Study 84
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1/Signature 1
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1/Signature 2
Study 501
Study 501/Experiment 1
Study 501/Experiment 1/Signature 1
Study 919/Experiment 1
Study 919/Experiment 1/Signature 1
Study 919/Experiment 1/Signature 2
Study 1030
Study 1098
Study 1112
Study 1120
Study 1128
Study 1134
Study 1136
Study 1137
Study 1138
Study 1153
Study 1154
Study 1155
Study 1164
Study 1171
Study 1199
Study 1273
Study 1274
Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children
Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1
Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1/Signature 1
Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 1/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 1/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 2/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 2/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 3
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 3/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 3/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 4
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 4/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 5
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 5/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 6
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 6/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 7
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 7/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 8
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 8/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 8/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 9
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 9/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 10
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 10/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 10/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 11
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 11/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 11/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 12
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 12/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 13
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 13/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 14
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 14/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 14/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 15
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 15/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 15/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 16
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 16/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 17
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 17/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 18
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 18/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 19
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 19/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 20
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 20/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 21
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 21/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 21/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 22
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 22/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 22/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 23
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 23/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 24
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 24/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 25
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 25/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 25/Signature 2
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 26
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 26/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 27
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 27/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 28
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 28/Signature 1
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 29
Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 29/Signature 1
Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients
Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 1
Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 1/Signature 1
Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 2
Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 2/Signature 1
Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 2/Signature 2
Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 3
Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 3/Signature 1
Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 3/Signature 2
Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 4
Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 4/Signature 1
Subgingival Microbiota during Healthy Pregnancy and Pregnancy Gingivitis/Experiment 4/Signature 2
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 1
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 1/Signature 1
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 2
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 2/Signature 1
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 3
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 3/Signature 1
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 4
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 4/Signature 1
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 5
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis/Experiment 5/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 1/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 2
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 2/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 3
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 3/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 4
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 4/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 5
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 5/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 6
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 6/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 7
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 7/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 7/Signature 2
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 8
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 8/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 9
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 9/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 10
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 10/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 11
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 11/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 12
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 12/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 13
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 13/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 14
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 14/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 15
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 15/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 16
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 16/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 17
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 17/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 18
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 18/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 19
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 19/Signature 1
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 20
Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 20/Signature 1
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 1
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 1/Signature 1
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 1/Signature 2
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 2
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 2/Signature 1
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 2/Signature 2
Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease/Experiment 7
Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease/Experiment 7/Signature 1
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 1
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 2
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 3
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 4
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 5
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 6
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 7
Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy
Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1
Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 1
Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 2
Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 3
Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy/Experiment 1/Signature 4
The biogeography of the mucosa-associated microbiome in health and disease
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 1/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 1/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 2/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 2/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 3
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 3/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 3/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 4
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 4/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 4/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 5
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 5/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 5/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 6
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 6/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 6/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 7
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 7/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 7/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 8
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 8/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 8/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 9
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 9/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 9/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 10
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 10/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 10/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 11
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 11/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 11/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 12
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 12/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 12/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 13
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 13/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 13/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 14
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 14/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 14/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 15
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 15/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 15/Signature 2
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 16
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 16/Signature 1
The biogeography of the mucosa-associated microbiome in health and disease/Experiment 16/Signature 2
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1/Signature 1
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1/Signature 2
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2/Signature 1
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2/Signature 2
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3/Signature 1
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3/Signature 2
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4/Signature 1
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4/Signature 2
The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial
The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial/Experiment 1
The conjunctival microbiome in health and trachomatous disease: a case control study/Experiment 4
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 1
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 1/Signature 1
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 2
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 2/Signature 1
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 3
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 3/Signature 1
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 4
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 4/Signature 1
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 5
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 5/Signature 1
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 6
The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 6/Signature 1
The effects of psyllium husk on gut microbiota composition and function in chronically constipated women of reproductive age using 16S rRNA gene sequencing analysis
The effects of psyllium husk on gut microbiota composition and function in chronically constipated women of reproductive age using 16S rRNA gene sequencing analysis/Experiment 1
The effects of psyllium husk on gut microbiota composition and function in chronically constipated women of reproductive age using 16S rRNA gene sequencing analysis/Experiment 1/Signature 1
The effects of psyllium husk on gut microbiota composition and function in chronically constipated women of reproductive age using 16S rRNA gene sequencing analysis/Experiment 1/Signature 2
The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls/Experiment 2/Signature 1
The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study
The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome
The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1
The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1/Signature 1
The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1/Signature 2
The gut microbiota and metabolite profiles are altered in patients with spinal cord injury/Experiment 2/Signature 2
The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1/Signature 1
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 1
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 1/Signature 1
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 1/Signature 2
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 2
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 2/Signature 1
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 2/Signature 2
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 3
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 3/Signature 1
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 3/Signature 2
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 4
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet/Experiment 4/Signature 1
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 1
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 2
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 3
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 4
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 5
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 6
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 7
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 8
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 9
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 10
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 11
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 12
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 13
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 14
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 15
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 16
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 17
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 18
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 19
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 20
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 21
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 22
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 23
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 24
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 25
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 26
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 27
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 28
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 29
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 30
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 31
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 32
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 33
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 34
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 35
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 36
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 37
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 38
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 39
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 40
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 41
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 42
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 43
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 44
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 45
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 46
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 47
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 48
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 49
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 50
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 51
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 52
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 53
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 54
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 55
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 56
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 57
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 58
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 59
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 60
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 61
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 62
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 63
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 64
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 65
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 66
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 67
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 68
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 69
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 70
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 71
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 72
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 73
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 74
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 75
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 76
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 77
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 78
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 79
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 80
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 81
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 82
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 83
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 84
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 85
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 86
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 87
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 88
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 89
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 90
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 91
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 92
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 93
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 94
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 95
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 96
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 97
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 98
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 99
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 100
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 101
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 102
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 103
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 104
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 105
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 106
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 107
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 108
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 109
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 110
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 111
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 112
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 113
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 114
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 115
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 116
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 117
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 118
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 119
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 120
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 121
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 122
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 123
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 124
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 125
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 126
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 127
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 128
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 129
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 130
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 131
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 132
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 133
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 134
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 135
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 136
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 137
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 138
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 139
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 140
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 141
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 142
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 143
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 144
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 145
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 146
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 147
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 148
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 149
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 150
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 151
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 152
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 153
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 154
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 155
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 156
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 157
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 158
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 159
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 160
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 161
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 162
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 163
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 164
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 165
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 166
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 167
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 168
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 169
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 170
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 171
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 172
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 173
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 174
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 175
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 176
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 177
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 178
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 179
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 180
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 181
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 182
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 183
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 184
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 185
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 186
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 187
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 188
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 189
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 190
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 191
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 192
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 193
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 194
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 195
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 196
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 197
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 198
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 199
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors/Experiment 200
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder/Experiment 4/Signature 2
The nasal microbiome in asthma/Experiment 2
The oral cavity and intestinal microbiome in children with functional constipation
The oral cavity and intestinal microbiome in children with functional constipation/Experiment 1
The oral cavity and intestinal microbiome in children with functional constipation/Experiment 1/Signature 1
The oral cavity and intestinal microbiome in children with functional constipation/Experiment 1/Signature 2
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 1
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 1/Signature 1
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 2
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 2/Signature 1
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 3
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study/Experiment 3/Signature 1
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 1
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 1/Signature 1
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 2
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 2/Signature 1
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 3
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 3/Signature 1
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 4
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study/Experiment 4/Signature 1
The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder
The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder/Experiment 1
The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder/Experiment 1/Signature 1
The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder/Experiment 1/Signature 2
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 1
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 1/Signature 1
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 1/Signature 2
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 2
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 2/Signature 1
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 2/Signature 2
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 3
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 3/Signature 1
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study/Experiment 3/Signature 2
[metals impact gut microbiota and metabolic risk in five African-origin populations]
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 1
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 1/Signature 1
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 2
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 2/Signature 1
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 3
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 3/Signature 1
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 4
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 4/Signature 1
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 5
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 5/Signature 1
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 5/Signature 2
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 6
Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women/Experiment 6/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 1/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 1/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 2/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 2/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 3
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 3/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 4
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 4/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 5
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 5/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 6
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 6/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 7
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 7/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 8
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 8/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 9
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 9/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 10
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 10/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 11
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 11/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 12
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 12/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 13
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 13/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 13/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 14
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 14/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 14/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 15
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 15/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 16
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 16/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 17
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 17/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 18
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 18/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 19
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 19/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 20
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 20/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 20/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 21
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 21/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 21/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 22
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 22/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 22/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 23
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 23/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 23/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 24
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 24/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 24/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 25
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 25/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 25/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 26
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 26/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 26/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 27
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 27/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 27/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 28
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 28/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 28/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 29
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 29/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 29/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 30
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 30/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 30/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 31
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 31/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 31/Signature 2
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 32
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 32/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 33
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 33/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 34
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 34/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 35
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 35/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 36
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 36/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 37
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 37/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 38
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 38/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 39
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 39/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 40
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 40/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 41
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 41/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 42
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 42/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 43
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 43/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 44
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 44/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 45
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 45/Signature 1
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 46
Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study/Experiment 46/Signature 1